Ophthalmology/Eye Institute

EmailEmail    |   Bookmark Page Bookmark  |   RSS Feeds RSS  |   Print Page Print  

Dale K. Heuer, MD
Professor & Chairman, Department of Ophthalmology
Director, Eye Institute
Phone: (414) 955-2020
FAX: (414) 955-6300
E-mail: dheuer@mcw.edu

Address:
The Eye Institute
925 N. 87th St.
Milwaukee, WI. 53226 

Patient Care Emphasis

  • Glaucoma
  • Ocular Hypertension
  • Hypotony
  • Congenital, Infantile, and Pediatric Glaucomas
  • Normal Pressure Glaucoma
  • Surgical Management of Glaucoma

Current Research Interests

  • Vice-Chair, National Eye Institute-funded Ocular Hypertension Treatment Study
  • Aqueous Shunting Procedures
  • Initial Treatment of Glaucoma
  • Ocular Hypertension
  • Normal Pressure Glaucoma

Honors and Society Memberships

  • Best Doctors in America, 1st, 2nd, 3rd, & 4th Editions
  • Honor Award, American Academy of Ophthalmology
  • American Academy of Ophthalmology
  • American Glaucoma Society
  • Association for Research in Vision and Ophthalmology
  • Association of University Professors of Ophthalmology
  • Christian Medical and Dental Society
  • Milwaukee Academy of Medicine
  • Milwaukee Ophthalmological Society
  • Research to Prevent Blindness
  • Wisconsin Academy of Ophthalmology

Education

  • MD, Northwestern University Medical School, Chicago, IL

Post Graduate Training

  • Internship, Medical College of Wisconsin Affiliated Hospitals, Milwaukee, WI
  • Residency, Ophthalmology, Medical College of Wisconsin - Eye Institute, Milwaukee, WI
  • Clinical Fellowship, Glaucoma, Bascom Palmer Eye Institute, Miami, FL
  • Research Fellowship, Glaucoma, Bascom Palmer Eye Institute, Miami, FL

Recent Publications

Han DP, Heuer DK. Intravitreal corticosteroid therapy: putting the problem of glaucoma in perspective. Arch Ophthalmol. 2012 Mar;130(3):380-2.

Brandt JD, Gordon MO, Gao F, Beiser JA, Miller JP, Kass MA, for the Ocular Hypertension Treatment Study Group Ophthalmology:  Adjusting intraocular pressure for central corneal thickness does not improve prediction models for primary open-angle glaucoma.  Ophthalmology 2012;119:437-442.111.

Gedde SJ, Parrish RK II, Budenz DL, Heuer DK:  Update on aqueous shunts.  Exp Eye Res 2011;93:284-290.

Musch DC, Gillespie BW, Niziol LM, Lichter PR, Varma R, for the CIGTS Study Group:  Intraocular pressure control and long-term visual field loss in the Collaborative Initial Glaucoma Treatment Study.  Ophthalmology 2011;118:1766–1773.

Chen PP, Musch DC, Niziol L for the CIGTS Study Group:  The effect of early posttrabeculectomy intraocular pressure spike in the Collaborative Initial Glaucoma Treatment Study. J Glaucoma 2011;20:211–214.

Budenz DL, Barton K, Feuer WJ, Schiffman J, Costa VP, Godfrey DG, Buys YM, for the Ahmed Baerveldt Comparison Study Group:  Treatment outcomes in the Ahmed Baerveldt Comparison Study after 1 year of follow-up.  Ophthalmology 2011;118:443–452.

Barton K, Gedde SJ, Budenz DL, Feuer WJ, Schiffman J, for the Ahmed Baerveldt Comparison Study Group:  The Ahmed Baerveldt Comparison Study:  Methodology, baseline patient characteristics, and intraoperative complications.  Ophthalmology 2011;118:435–442.

Gao F, Miller JP, Xiong C, Beiser JA, Gordon M, the Ocular Hypertension Treatment Study (OHTS) Group:  A joint-modeling approach to assess the impact of biomarker variability on the risk of developing clinical outcome.  Stat Methods Appl 2011;20:83–100.

Artes PH, Chauhan BC, Keltner JL, Cello KE, Johnson CA, Anderson DR, Gordon MO, Kass MA, for the Ocular Hypertension Treatment Study Group:  Longitudinal and cross-sectional analyses of visual field progression in participants of the Ocular Hypertension Treatment Study.  Arch Ophthalmol 2010;128:1528-1532.

Radcliffe NM, Musch DC, Niziol LM, Liebmann JM, Ritch R, MD, on behalf of the Collaborative Initial Glaucoma Treatment Study Group:  The effect of trabeculectomy on intraocular pressure of the untreated fellow eye in the Collaborative Initial Glaucoma Treatment Study.  Ophthalmology 2010;117:2055–2060.

Bhorade AM, Wilson BS, Gordon MO, Palmberg P, Weinreb RN, Miller E, Chang RT, Kass MA, for the Ocular Hypertension Treatment Study Group:  The utility of the monocular trial.  Data from the Ocular Hypertension Treatment Study.  Ophthalmology 2010;117:2047–2054.

Barnett EM, Fantin A, Wilson BS, Kass MA, Gordon MO, for the Ocular Hypertension Treatment Study Group:  The Incidence of Retinal Vein Occlusion in the Ocular Hypertension Treatment Study.  Ophthalmology 2010;117:484–488.

Kass MA, Gordon MO, Gao F, Heuer DK, Higginbotham EJ, Johnson CA, Keltner JK, Miller JP, Parrish RK, Wilson MR, for the Ocular Hypertension Treatment Study Group:  Delaying Treatment of Ocular Hypertension.  The Ocular Hypertension Treatment Study.  Arch Ophthalmol 2010;128:276-287.

Gedde SJ, Heuer DK, Parrish RK II; the Tube Versus Trabeculectomy Study Group:  Review of results from the Tube Versus Trabeculectomy Study.  Curr Opin Ophthalmol 2010;21:123-128.

Gedde SJ, Schiffman JC, Feuer WJ, Herndon LW, Brandt JD, Budenz DL, on behalf of the Tube Versus Trabeculectomy Study Group:  Three-year follow-up of the tube versus trabeculectomy study.  Am J Ophthalmol 2009;148:670-684.

Bhorade AM, Gordon MO, Wilson B, Weinreb RN, Kass MA for the Ocular Hypertension Treatment Study Group:  Variability of intraocular pressure measurements in observation participants in the Ocular Hypertension Treatment Study.  Ophthalmology 2009;116:717-724.

Janz NK, Musch DC,  Gillespie BW,  Wren PA, Niziol LM, for the Collaborative Initial Glaucoma Treatment Study (CIGTS) Investigators:  Evaluating clinical change and visual function concerns in drivers and non-drivers with glaucoma.  Invest Ophthalmol Vis Sci 2009;50:1718–1725.

Parrish RK II, Feuer WJ, Schiffman JD, Lichter PR, Musch DC, on behalf of the CIGTS Optic Disc Study Group:  Five-year follow-up optic disc findings of the Collaborative Initial Glaucoma Treatment Study.  Am J Ophthalmol 2009;147:717-724.

Rauscher FM, Gedde SJ, Schiffman JC, Feuer WJ, Barton K, Lee RK, on behalf of The Tube Versus Trabeculectomy Study Group:  Motility disturbances in the Tube Versus Trabeculectomy Study during the first year of follow-up.  Am J Ophthalmol 2009;147:458-466.

Musch DC, Gillespie BW, Lichter PR, Niziol LM, Janz NK, the CIGTS Study Investigators:  Visual field progression in the Collaborative Initial Glaucoma Treatment Study.  The impact of treatment and other baseline factors.  Ophthalmology 2009;116:200-207.

webmaster@mcw.edu
© 2014 Medical College of Wisconsin
Page Updated 09/11/2014